Hjem › Ikke-småcellet lungekreft › Arizona › Phoenix
Kliniske studier for Ikke-småcellet lungekreft i Phoenix, AZ
20 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Phoenix (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
- Exelixis Clinical Site #67, Phoenix
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
RekruttererFase 1/2
- Research Site, Phoenix
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruttererFase 3
- Ironwood Cancer & Research Centers, Phoenix
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruttererObservasjonsstudie
- Mayo Clinic Hospital, Phoenix
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
RekruttererFase 3
- Mayo Clinic in Arizona - Phoenix ( Site 0147), Phoenix
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekruttererFase 3
- City of Hope, Phoenix, Phoenix
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RekruttererFase 3
- Clinical Study Site, Phoenix
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Banner University Medical Center Phoenix, Phoenix
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RekruttererFase 1
- Mayo Clinic, Phoenix
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RekruttererFase 1/2
- Mayo Clinic Arizona, Phoenix
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
RekruttererFase 1/2
- Mayo Clinic Arizona, Phoenix
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruttererFase 3
- Mayo Clinic Hospital in Arizona, Phoenix
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
RekruttererFase 1/2
- Mayo Clinic Hospital - Arizona, Phoenix
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruttererFase 1/2
- USOR HonorHealth, Phoenix
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RekruttererFase 1
- Mayo Clinic Hospital, Phoenix
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RekruttererFase 1
- Mayo Clinic Hospital, Phoenix
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RekruttererFase 3
- Mayo Clinic Hospital in Arizona, Phoenix
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RekruttererFase 1
- Mayo Clinic Comprehensive Cancer Center, Phoenix
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- Cancer Center at Saint Joseph's, Phoenix
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
RekruttererObservasjonsstudie
- Mayo Clinic in Arizona, Phoenix
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY120 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH56 studier
- Washington, DC55 studier
Andre studier i Phoenix
- Brystkreft25 studier
- Kolorektal kreft25 studier
- Fedme22 studier
- Metastatisk kreft20 studier
- Hjertesvikt18 studier
- Prostatakreft17 studier
- Kreft (alle typer)17 studier
- Multipelt myelom16 studier
- Pankreaskreft16 studier
- Kardiovaskulær sykdom16 studier
- Alzheimers sykdom15 studier
- Overvekt15 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.